Company Filing History:
Years Active: 2010-2012
Title: Christiane Feron: Innovator in Neisserial Vaccine Compositions
Introduction
Christiane Feron is a prominent inventor based in Rixensart, Belgium. She has made significant contributions to the field of vaccine development, particularly focusing on neisserial vaccine compositions. With a total of 2 patents, her work has the potential to enhance the safety and effectiveness of vaccines used in human medicine.
Latest Patents
One of her latest patents involves vaccine compositions comprising L2 and/or L3 immunotype lipooligosaccharides from LGTB-neisseria meningitidis. This invention relates to the processes of creating novel engineered meningococcal strains that are more suitable for producing neisserial outer-membrane vesicle vaccines. The patent describes advantageous processes and vaccine products that utilize novel LOS subunit or meningococcal outer-membrane vesicle vaccines, which have been improved for safety and efficacy. It also details combinations of gene downregulations, such as PorA and OpA, PorA and OpC, OpA and OpC, and others. Additionally, the patent highlights the optimal mutation of lgtB for effectively using L3 and/or L2 LOS in vaccine compositions.
Career Highlights
Christiane has worked with notable organizations, including GlaxoSmithKline Biologicals and Utrecht University. Her experience in these institutions has contributed to her expertise in vaccine research and development.
Collaborations
Some of her coworkers include Ralph Leon Biemans and Philippe Denoel, who have collaborated with her on various projects in the field of vaccine innovation.
Conclusion
Christiane Feron is a dedicated inventor whose work in neisserial vaccine compositions is paving the way for safer and more effective vaccines. Her contributions to the field are invaluable and continue to impact medical science positively.